Trabectedin Active Not Recruiting Phase 3 Trials for Dedifferentiated Liposarcoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04979442Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma